Sponsor:
Georgiamune Inc
Code:
NCT06425926
Conditions
Melanoma Stage IV
Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GIM-531
Anti-PD-1 monoclonal antibody
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Georgiamune Inc on 2025-02-28.